In one paragraphArticle in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
5 authors at 1 institution in 1 country.
Michael T ForresterDivision of Pulmonary, Allergy and Critical Care Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.ORCID 0009-0007-4665-4164 Jacob R EgolDepartment of Cell Biology, Duke University School of Medicine, Durham, NC, 27710, USA.
Aleksandra TataDepartment of Cell Biology, Duke University School of Medicine, Durham, NC, 27710, USA.
Purushothama Rao TataDivision of Pulmonary, Allergy and Critical Care Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.ORCID 0000-0003-4837-0337 Matthew W FosterDivision of Pulmonary, Allergy and Critical Care Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.ORCID 0000-0003-0212-2346 Duke University · US
Funding
Molecular control of a novel transitional cell state in alveolar regenerationR01HL153375 · NHLBI · DUKE UNIVERSITY · PI Purushothama Rao Tata · 2020 to 2026
$3.4MDuke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)T32HL160494 · NHLBI · DUKE UNIVERSITY · PI Jennifer L. Ingram, DAVID MARTIN MURDOCH · 2022 to 2026
$2.6MCellular crosstalk and molecular mechanisms in the initiation and progression of pulmonary fibrosisR01HL160939 · NHLBI · DUKE UNIVERSITY · PI TATA, PURUSHOTHAMA RAO · 2022 to 2025
$2.1MDevelopment of a protein palmitoylation assay to monitor treatment of CLN1 Batten DiseaseR41HD105560 · NICHD · CIRCUMVENT PHARMACEUTICALS, INC. · PI FOSTER, MATTHEW WOLF, SCOTT, ANNA INGRID · 2021 to 2021
$305kNHLBI NIH HHS R01 HL153375NHLBI NIH HHS R01 HL160939NHLBI NIH HHS T32 HL160494NICHD NIH HHS R41 HD105560
6 · The paper itselfAbstract
Proteins undergo reversible
Indexed as
chemoproteomics S-palmitoylationcysteine proteomicsFragpipeisobaric labelingS-acylationS-TrapSuspension trappingSwisspalmthioesterTMT
Identifiers
PMID38585928
PMCPMC10996552
OpenAlexW4393214903
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390